Clinical Trials Insight: 700037890
Phase of Trial: Phase I
Latest Information Update: 04 May 2012
At a glance
- Drugs EVT 401 (Primary)
- Indications Chronic obstructive pulmonary disease; Irritable bowel syndrome; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Evotec AG
- 04 May 2012 Status changed from recruiting to completed.
- 29 Jun 2009 Status changed from active, no longer recruiting to completed, according to an Evotec media release.
- 13 Oct 2008 New trial record.